AbbVie (United States)

6.1k papers and 131.0k indexed citations i.

About

In recent decades, authors affiliated with AbbVie (United States) have published 6.1k papers, which have received a total of 131.0k indexed citations. Scholars at this organization have produced 988 papers in Molecular Biology, 829 papers in Oncology and 823 papers in Immunology on the topics of Chronic Lymphocytic Leukemia Research (588 papers), Rheumatoid Arthritis Research and Therapies (403 papers) and Lymphoma Diagnosis and Treatment (349 papers). Their work is cited by papers focused on Molecular Biology (29.2k citations), Immunology (18.0k citations) and Oncology (17.5k citations). Authors at AbbVie (United States) collaborate with scholars in United States, Germany and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of AbbVie (United States)'s most productive authors include Geoff G. Z. Zhang, Ahmed M. Soliman, Lynne S. Taylor, Joel D. Leverson, Aileen L. Pangan, Rolando Burgos, Ahmed Hamed Salem, Dushan Boroyevich, Carl J. Lavie and Gary A. Gintant.

In The Last Decade

Fields of papers published by authors at AbbVie (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with AbbVie (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with AbbVie (United States) at the time of their publication.

Countries citing scholars working at AbbVie (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at AbbVie (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AbbVie (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AbbVie (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, itโ€”like all bibliographic datasetsโ€”has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholarโ€™s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025